Ketamine derivative gets FDA approval for adjunct use in treatment-resistant major depressive disorder.
https://www.scientificamerican.com/article/fda-approves-esketamine-the-first-major-depression-treatment-to-reach-u-s-market-in-decades/
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.
